根据协议,4D将向$Fortress Biotech(FBIO)$ 旗下子公司Aevitas支付总计1.4亿美元,用于潜在的后期开发、监管和销售里程碑,以及销售特许权使用费。
两家公司表示,这笔款...查看全文
美股滚雪球2021-11-16 16:05
别人是卖药赚钱,$Fortress Biotech(FBIO)$ 是卖公司:阿斯利康收购了它的子公司Caelum Biosciences,收到预付款5690万美元,又一家子公司Journey Medical Corporation准备IPO。$恒瑞医药(SH600276)$ $长春高新(SZ000661)$查看全文
美股滚雪球2021-09-30 10:25
$Fortress Biotech(FBIO)$ 因阿斯利康名下的ALXN并购了自己的子公司Caelum而大涨,FBIO有望获得6400万美元,这是文中介绍的积极抓住子公司资产的合作、出售等商业化机会。 $恒瑞医药(SH600276)$ $沃森生物(SZ300142)$查看全文
美股滚雪球2021-06-07 09:59
本文摘要:
1、Hub-and-Spoke模式为何在创新药行业兴起?
2、Hub-and-Spoke模式的优点和缺点有哪些?
3、Hub-and-Spoke模式的案例分析
$Centessa(CNTA)$ $BridgeBio Pharma(BBIO)$ $Fortress Biotech(FBIO)$查看全文
美股律师郝俊波2020-12-01 17:43
$Fortress Biotech(FBIO)$ 【 Fortress Biotech Inc最新证券诉讼 】
Fortress Biotech Inc (FBIO)因证券欺诈案已经于近日被投资者诉至法院。在目前的诉讼中投资者指控该公司在2019年12月11日至2020年10月9日期间就公司的业务运营状况和合规政策进行虚假陈述,为向投资者披露以下重大不利事实...查看全文
$Fortress Biotech, Inc.(FBIO)$ 8-K - Current report Filed: 2016-09-26 AccNo: 0001144204-16-125360 Size: 19 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 9.01: Financial Statements and Exhibits 网页链接
$Fortress Biotech, Inc.(FBIO)$ 8-K - Current report Filed: 2016-09-20 AccNo: 0001144204-16-124611 Size: 23 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a ...
$Fortress Biotech, Inc.(FBIO)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2016-09-15 AccNo: 0001193125-16-710438 Size: 106 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2016-09-12 AccNo: 0001193125-16-706996 Size: 33 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2016-08-18 AccNo: 0001144204-16-120232 Size: 402 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2016-08-17 AccNo: 0001144204-16-120012 Size: 39 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ 8-K - Current report Filed: 2016-08-17 AccNo: 0001144204-16-120000 Size: 274 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Fortress Biotech, Inc.(FBIO)$ SC TO-T - Tender offer statement by Third Party Filed: 2016-08-12 AccNo: 0001193125-16-680011 Size: 968 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ SC TO-C - Written communication relating to an issuer or third party Filed: 2016-08-12 AccNo: 0001193125-16-679993 Size: 35 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ 8-K - Current report Filed: 2016-08-12 AccNo: 0001193125-16-679992 Size: 34 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接